Emergent BioSolutions (EBS) Equity Ratio (2010 - 2026)

Emergent BioSolutions' Equity Ratio history runs 17 years deep, the most recent figure standing at 0.4 for Q1 2026.

• In Q1 2026, Equity Ratio rose 2.22% year-over-year to 0.4; the TTM figure through Mar 2026 stood at 0.4 (up 2.22% YoY), while the FY2025 annual figure was 0.4, up 14.08% from the prior year.
• Equity Ratio was 0.4 for Q1 2026 at Emergent BioSolutions, roughly flat from 0.4 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.56 in Q1 2022 to a low of 0.26 in Q2 2024.
• Historically, Equity Ratio has averaged 0.41 across 5 years, with a median of 0.4 in 2026.
• The sharpest annual moves came in 2024 and 2025: Equity Ratio plunged 41.93% in 2024, then soared 48.25% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.44 in 2022, then fell by 18.74% to 0.36 in 2023, then declined by 2.45% to 0.35 in 2024, then gained by 14.08% to 0.4 in 2025, then declined by 0.04% to 0.4 in 2026.
• The last three Equity Ratio figures came in at 0.4 (Q1 2026), 0.4 (Q4 2025), and 0.4 (Q3 2025), per Business Quant data.